Larimar Therapeutics
LRMR
LRMR
135 hedge funds and large institutions have $275M invested in Larimar Therapeutics in 2025 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 60 increasing their positions, 26 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
17% more funds holding
Funds holding: 115 → 135 (+20)
2.58% more ownership
Funds ownership: 97.31% → 99.89% (+2.6%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
135
Holding in Top 10
1
Calls
$22.7M
Puts
$2.13M
Top Buyers
| 1 | +$35.2M | |
| 2 | +$11.7M | |
| 3 | +$7.12M | |
| 4 |
Goldman Sachs
New York
|
+$5.41M |
| 5 |
Millennium Management
New York
|
+$4.66M |
Top Sellers
| 1 | -$3.35M | |
| 2 | -$2.88M | |
| 3 | -$1.46M | |
| 4 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
-$1.23M |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$888K |
